Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519883
Status:
UNKNOWN
Last Update Posted:
2014-08-25
First Post:
2007-08-22
Brief Title:
Randomized Anastrozole Exercise Trial
Sponsor:
British Columbia Cancer Agency
Organization:
British Columbia Cancer Agency
Study Overview
Official Title:
Randomized Anastrozole Exercise Trial The RAE Study
Status:
UNKNOWN
Status Verified Date:
2014-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RAE
Brief Summary:
This is a randomized phase III trial of a 12 week exercise program followed by a 36 week voluntary self-directed exercise program total 48 weeks compared to standard supportive care The purpose of the trial is to determine whether the exercise program is better than standard supportive care to decrease the muscle and joint aches musculoskeletal symptoms that result from aromatase inhibitors
Hypothesis An exercise program that includes stretching strengthening and aerobic components may improve physical quality of life among women with musculoskeletal symptoms who are taking aromatase inhibitors
Hypothesis An exercise program that includes stretching strengthening and aerobic components may improve physical quality of life among women with musculoskeletal symptoms who are taking aromatase inhibitors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None